Clinical Trial Update: Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections

View source ↗

Summary

Clinical trial update for clarithromycin/clarithromycin-based therapy in atypical Mycobacterium pulmonary infections; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-tuberculous Mycobacterial Pulmonary Infection

Drugs mentioned

• Klaricid (clarithromycin)

Snippet

Sponsor: Mylan Inc. | Conditions: Mycobacterium Infections, Atypical | Status: COMPLETED | Results posted: 2016-09-19